| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neuroprotective Agents | 19 | 2018 | 941 | 4.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 15 | 2017 | 1414 | 2.760 |
Why?
|
| Hypoxia-Ischemia, Brain | 6 | 2017 | 333 | 2.030 |
Why?
|
| Melatonin | 6 | 2018 | 721 | 1.640 |
Why?
|
| Spinal Cord | 8 | 2015 | 1809 | 1.570 |
Why?
|
| Serotonin | 4 | 2018 | 1017 | 1.500 |
Why?
|
| Receptor, Melatonin, MT1 | 4 | 2018 | 30 | 1.220 |
Why?
|
| Methazolamide | 3 | 2016 | 9 | 1.020 |
Why?
|
| Apoptosis | 25 | 2018 | 9727 | 1.010 |
Why?
|
| Frizzled Receptors | 3 | 2014 | 91 | 1.000 |
Why?
|
| SOX9 Transcription Factor | 4 | 2018 | 146 | 0.990 |
Why?
|
| Wnt Proteins | 3 | 2013 | 721 | 0.990 |
Why?
|
| Cell Death | 14 | 2015 | 1706 | 0.940 |
Why?
|
| Cytochromes c | 7 | 2015 | 180 | 0.930 |
Why?
|
| Tryptophan | 2 | 2015 | 478 | 0.890 |
Why?
|
| Superoxide Dismutase | 8 | 2015 | 597 | 0.880 |
Why?
|
| Mitochondria | 13 | 2015 | 3520 | 0.880 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2017 | 496 | 0.810 |
Why?
|
| Huntington Disease | 5 | 2011 | 1124 | 0.770 |
Why?
|
| HMGB1 Protein | 2 | 2014 | 133 | 0.740 |
Why?
|
| Neural Stem Cells | 3 | 2017 | 851 | 0.670 |
Why?
|
| Neurons | 14 | 2017 | 9338 | 0.660 |
Why?
|
| Infarction, Middle Cerebral Artery | 4 | 2017 | 475 | 0.660 |
Why?
|
| Caspase 1 | 4 | 2009 | 224 | 0.650 |
Why?
|
| MicroRNAs | 5 | 2018 | 3752 | 0.650 |
Why?
|
| Brain Ischemia | 7 | 2018 | 3265 | 0.650 |
Why?
|
| Astrocytes | 5 | 2017 | 1270 | 0.640 |
Why?
|
| Caspases | 10 | 2015 | 928 | 0.630 |
Why?
|
| Cytoprotection | 2 | 2014 | 210 | 0.580 |
Why?
|
| Wnt1 Protein | 2 | 2014 | 118 | 0.570 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2006 | 38 | 0.560 |
Why?
|
| Disease Models, Animal | 21 | 2017 | 18029 | 0.550 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2016 | 126 | 0.550 |
Why?
|
| Caspase 3 | 8 | 2016 | 758 | 0.550 |
Why?
|
| Hydrogen Peroxide | 3 | 2014 | 731 | 0.540 |
Why?
|
| SOXB1 Transcription Factors | 1 | 2017 | 284 | 0.540 |
Why?
|
| Motor Neurons | 3 | 2015 | 844 | 0.530 |
Why?
|
| Pemphigus | 3 | 2006 | 103 | 0.520 |
Why?
|
| Brain Edema | 2 | 2016 | 617 | 0.500 |
Why?
|
| Substantia Nigra | 1 | 2016 | 353 | 0.500 |
Why?
|
| Cerebellar Nuclei | 1 | 2014 | 52 | 0.490 |
Why?
|
| Hemin | 1 | 2014 | 49 | 0.490 |
Why?
|
| Brain Injuries | 2 | 2018 | 2025 | 0.470 |
Why?
|
| Animals | 55 | 2019 | 168757 | 0.460 |
Why?
|
| Mice, Transgenic | 12 | 2017 | 9734 | 0.450 |
Why?
|
| Globins | 1 | 2014 | 415 | 0.450 |
Why?
|
| Nerve Tissue Proteins | 6 | 2017 | 4462 | 0.440 |
Why?
|
| Keratinocytes | 4 | 2004 | 798 | 0.430 |
Why?
|
| Oxidative Stress | 5 | 2018 | 3086 | 0.420 |
Why?
|
| Carbonic Anhydrase Inhibitors | 2 | 2009 | 95 | 0.410 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2014 | 314 | 0.390 |
Why?
|
| Muscular Atrophy | 1 | 2014 | 349 | 0.390 |
Why?
|
| Antioxidants | 5 | 2013 | 1663 | 0.390 |
Why?
|
| Mice | 33 | 2019 | 81183 | 0.380 |
Why?
|
| Central Nervous System Agents | 1 | 2011 | 72 | 0.380 |
Why?
|
| Autophagy | 3 | 2017 | 1300 | 0.370 |
Why?
|
| Parkinsonian Disorders | 1 | 2013 | 275 | 0.370 |
Why?
|
| Neuroglia | 2 | 2015 | 927 | 0.370 |
Why?
|
| Liver Diseases | 1 | 2018 | 1253 | 0.360 |
Why?
|
| Drug Design | 1 | 2015 | 1076 | 0.360 |
Why?
|
| Blotting, Western | 9 | 2019 | 5179 | 0.340 |
Why?
|
| Stroke | 5 | 2018 | 9981 | 0.340 |
Why?
|
| Hedgehog Proteins | 1 | 2014 | 783 | 0.330 |
Why?
|
| Membrane Potential, Mitochondrial | 5 | 2014 | 297 | 0.330 |
Why?
|
| Reperfusion Injury | 2 | 2013 | 1026 | 0.330 |
Why?
|
| Osteoporosis | 1 | 2018 | 1580 | 0.330 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2016 | 1018 | 0.330 |
Why?
|
| Acantholysis | 2 | 2006 | 11 | 0.320 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2019 | 8301 | 0.320 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2009 | 117 | 0.320 |
Why?
|
| Cells, Cultured | 12 | 2017 | 19229 | 0.310 |
Why?
|
| Gene Expression Regulation | 6 | 2017 | 12072 | 0.310 |
Why?
|
| Autoantibodies | 3 | 2006 | 2035 | 0.300 |
Why?
|
| Stem Cell Transplantation | 2 | 2017 | 1620 | 0.300 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 752 | 0.300 |
Why?
|
| Neurogenesis | 1 | 2014 | 838 | 0.300 |
Why?
|
| Corpus Striatum | 1 | 2013 | 1221 | 0.290 |
Why?
|
| Cell Proliferation | 7 | 2018 | 10481 | 0.290 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1526 | 0.290 |
Why?
|
| beta Catenin | 1 | 2012 | 1059 | 0.280 |
Why?
|
| Neural Tube Defects | 1 | 2009 | 256 | 0.280 |
Why?
|
| Signal Transduction | 13 | 2019 | 23403 | 0.280 |
Why?
|
| Neurodegenerative Diseases | 4 | 2011 | 1061 | 0.280 |
Why?
|
| Embryonic Stem Cells | 1 | 2014 | 1294 | 0.280 |
Why?
|
| Ribosomal Proteins | 1 | 2009 | 360 | 0.280 |
Why?
|
| Stem Cells | 4 | 2017 | 3567 | 0.280 |
Why?
|
| Caspase 9 | 4 | 2014 | 188 | 0.280 |
Why?
|
| Deep Brain Stimulation | 1 | 2014 | 748 | 0.280 |
Why?
|
| Enzyme Activation | 8 | 2014 | 3701 | 0.280 |
Why?
|
| Chloride Channels | 2 | 2019 | 227 | 0.270 |
Why?
|
| Cognition Disorders | 2 | 2019 | 4043 | 0.270 |
Why?
|
| Ischemia | 1 | 2014 | 1907 | 0.260 |
Why?
|
| Oxidopamine | 2 | 2016 | 169 | 0.250 |
Why?
|
| Receptor, Melatonin, MT2 | 2 | 2018 | 77 | 0.250 |
Why?
|
| Receptors, Neurokinin-1 | 2 | 2015 | 129 | 0.250 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 11366 | 0.250 |
Why?
|
| Carrier Proteins | 5 | 2008 | 5021 | 0.250 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1676 | 0.240 |
Why?
|
| Tyrosine 3-Monooxygenase | 2 | 2016 | 375 | 0.240 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2013 | 643 | 0.230 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 2015 | 1375 | 0.230 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 2077 | 0.220 |
Why?
|
| Sleep | 1 | 2018 | 4623 | 0.220 |
Why?
|
| Glioma | 4 | 2018 | 3401 | 0.210 |
Why?
|
| Minocycline | 1 | 2003 | 163 | 0.210 |
Why?
|
| Epidermis | 2 | 2004 | 528 | 0.200 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3386 | 0.200 |
Why?
|
| Cell Survival | 4 | 2016 | 5882 | 0.200 |
Why?
|
| Bromodeoxyuridine | 3 | 2017 | 322 | 0.190 |
Why?
|
| Endoplasmic Reticulum | 2 | 2006 | 1144 | 0.190 |
Why?
|
| Blood-Brain Barrier | 2 | 2017 | 1017 | 0.190 |
Why?
|
| Transfection | 5 | 2016 | 5892 | 0.190 |
Why?
|
| Membrane Potentials | 2 | 2017 | 1137 | 0.190 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2001 | 200 | 0.180 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2016 | 1086 | 0.170 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2018 | 17446 | 0.170 |
Why?
|
| Hippocampus | 3 | 2017 | 3675 | 0.170 |
Why?
|
| Down-Regulation | 3 | 2017 | 3002 | 0.170 |
Why?
|
| Receptors, Melatonin | 1 | 2018 | 31 | 0.170 |
Why?
|
| Brain | 5 | 2014 | 26385 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 7 | 2017 | 21827 | 0.160 |
Why?
|
| Cell Differentiation | 4 | 2017 | 11483 | 0.160 |
Why?
|
| Membrane Transport Modulators | 1 | 2017 | 24 | 0.160 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinase 2 | 3 | 2006 | 33 | 0.160 |
Why?
|
| Rats | 7 | 2017 | 24260 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2017 | 66 | 0.150 |
Why?
|
| Liver | 1 | 2013 | 7474 | 0.150 |
Why?
|
| Nortriptyline | 2 | 2008 | 81 | 0.150 |
Why?
|
| Hexokinase | 1 | 2017 | 125 | 0.150 |
Why?
|
| Dynamins | 1 | 2017 | 152 | 0.140 |
Why?
|
| Sympatholytics | 1 | 2016 | 83 | 0.140 |
Why?
|
| Interleukin-1beta | 2 | 2015 | 972 | 0.140 |
Why?
|
| Cerebral Cortex | 6 | 2017 | 5708 | 0.140 |
Why?
|
| Apoptosis Inducing Factor | 2 | 2014 | 55 | 0.140 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 3 | 2006 | 143 | 0.140 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 5853 | 0.140 |
Why?
|
| Time Factors | 8 | 2014 | 40075 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2019 | 363 | 0.140 |
Why?
|
| Dendrites | 1 | 2019 | 485 | 0.140 |
Why?
|
| Brain Neoplasms | 4 | 2018 | 8863 | 0.130 |
Why?
|
| Cell Line | 6 | 2019 | 15997 | 0.130 |
Why?
|
| Angiopoietin-1 | 1 | 2015 | 114 | 0.130 |
Why?
|
| Membrane Glycoproteins | 2 | 2004 | 3768 | 0.130 |
Why?
|
| Hybrid Cells | 1 | 2015 | 441 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2014 | 3505 | 0.130 |
Why?
|
| Enkephalin, Leucine | 1 | 2014 | 16 | 0.130 |
Why?
|
| Up-Regulation | 3 | 2014 | 4217 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 528 | 0.130 |
Why?
|
| Dacarbazine | 1 | 2018 | 566 | 0.130 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 1 | 2014 | 54 | 0.130 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2014 | 44 | 0.130 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 238 | 0.130 |
Why?
|
| Neurotensin | 1 | 2014 | 61 | 0.120 |
Why?
|
| HeLa Cells | 3 | 2006 | 3128 | 0.120 |
Why?
|
| Stereoisomerism | 1 | 2015 | 624 | 0.120 |
Why?
|
| Humans | 38 | 2018 | 744343 | 0.120 |
Why?
|
| Vasospasm, Intracranial | 1 | 2016 | 208 | 0.120 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 87 | 0.120 |
Why?
|
| Substance P | 1 | 2015 | 335 | 0.120 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2016 | 437 | 0.120 |
Why?
|
| Male | 25 | 2019 | 350118 | 0.120 |
Why?
|
| RNA, Messenger | 4 | 2016 | 13033 | 0.120 |
Why?
|
| Malondialdehyde | 1 | 2013 | 105 | 0.120 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 146 | 0.120 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2014 | 162 | 0.120 |
Why?
|
| Riluzole | 1 | 2013 | 55 | 0.110 |
Why?
|
| Prediabetic State | 1 | 2019 | 499 | 0.110 |
Why?
|
| Medulla Oblongata | 1 | 2014 | 243 | 0.110 |
Why?
|
| Neuronavigation | 1 | 2014 | 167 | 0.110 |
Why?
|
| Hep G2 Cells | 1 | 2014 | 393 | 0.110 |
Why?
|
| Subcellular Fractions | 1 | 2014 | 547 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2012 | 1889 | 0.110 |
Why?
|
| Gene Expression Profiling | 3 | 2013 | 9438 | 0.110 |
Why?
|
| Nerve Fibers | 1 | 2016 | 687 | 0.110 |
Why?
|
| Biological Assay | 1 | 2016 | 652 | 0.110 |
Why?
|
| DNA Fragmentation | 2 | 2004 | 242 | 0.110 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2019 | 1116 | 0.110 |
Why?
|
| Dipyrone | 1 | 2011 | 9 | 0.100 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 351 | 0.100 |
Why?
|
| Aspartate Aminotransferases | 1 | 2013 | 418 | 0.100 |
Why?
|
| Mutation | 3 | 2013 | 29786 | 0.100 |
Why?
|
| Permeability | 1 | 2014 | 738 | 0.100 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2014 | 1157 | 0.100 |
Why?
|
| Choline | 1 | 2013 | 493 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2018 | 2634 | 0.100 |
Why?
|
| Postmortem Changes | 1 | 2011 | 126 | 0.100 |
Why?
|
| Creatine | 1 | 2013 | 421 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 500 | 0.100 |
Why?
|
| Lentivirus | 1 | 2014 | 501 | 0.100 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2014 | 504 | 0.100 |
Why?
|
| Aspartic Acid | 1 | 2013 | 576 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 2007 | 0.100 |
Why?
|
| Oncogenes | 1 | 2016 | 1265 | 0.090 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2012 | 443 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 216 | 0.090 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2009 | 424 | 0.090 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 1422 | 0.090 |
Why?
|
| Cell Movement | 3 | 2017 | 5217 | 0.090 |
Why?
|
| Embryo, Mammalian | 2 | 2017 | 1701 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 4751 | 0.090 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1338 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1114 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2018 | 1988 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2012 | 463 | 0.090 |
Why?
|
| Amino Acid Sequence | 3 | 2009 | 13815 | 0.090 |
Why?
|
| Enzyme Inhibitors | 2 | 2018 | 3798 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2008 | 898 | 0.090 |
Why?
|
| Regeneration | 1 | 2018 | 1485 | 0.090 |
Why?
|
| In Situ Hybridization | 1 | 2013 | 1950 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2014 | 1655 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2011 | 445 | 0.080 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 18111 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2009 | 252 | 0.080 |
Why?
|
| Neurotransmitter Agents | 1 | 2012 | 647 | 0.080 |
Why?
|
| Neural Tube | 1 | 2009 | 46 | 0.080 |
Why?
|
| Membrane Proteins | 2 | 2003 | 7880 | 0.080 |
Why?
|
| Disease Progression | 4 | 2013 | 13284 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2014 | 1224 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2018 | 8428 | 0.080 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 3129 | 0.080 |
Why?
|
| Osteosarcoma | 1 | 2014 | 881 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2018 | 2421 | 0.080 |
Why?
|
| Cell Separation | 1 | 2014 | 1751 | 0.080 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 1866 | 0.080 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 2886 | 0.080 |
Why?
|
| Mitochondrial Membranes | 1 | 2009 | 175 | 0.080 |
Why?
|
| Genome-Wide Association Study | 2 | 2018 | 12261 | 0.080 |
Why?
|
| Pentachlorophenol | 1 | 2007 | 10 | 0.080 |
Why?
|
| Phenanthrolines | 1 | 2007 | 55 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 2014 | 882 | 0.070 |
Why?
|
| Analysis of Variance | 3 | 2013 | 6365 | 0.070 |
Why?
|
| Rats, Wistar | 3 | 2019 | 1901 | 0.070 |
Why?
|
| Blotting, Northern | 1 | 2009 | 1581 | 0.070 |
Why?
|
| Maze Learning | 2 | 2019 | 478 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2016 | 1373 | 0.070 |
Why?
|
| Caspases, Initiator | 1 | 2006 | 32 | 0.070 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2008 | 189 | 0.070 |
Why?
|
| Cytotoxins | 1 | 2007 | 153 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2088 | 0.070 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 789 | 0.070 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2016 | 1632 | 0.070 |
Why?
|
| Antigens, CD | 1 | 2016 | 4026 | 0.070 |
Why?
|
| Meningioma | 1 | 2014 | 1209 | 0.070 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3589 | 0.060 |
Why?
|
| DNA, Complementary | 1 | 2009 | 2050 | 0.060 |
Why?
|
| Caspase 6 | 2 | 2001 | 15 | 0.060 |
Why?
|
| Cricetinae | 1 | 2009 | 2472 | 0.060 |
Why?
|
| Gene Regulatory Networks | 1 | 2013 | 1708 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 3920 | 0.060 |
Why?
|
| Copper | 1 | 2007 | 366 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3420 | 0.060 |
Why?
|
| COS Cells | 1 | 2006 | 1161 | 0.060 |
Why?
|
| Infant, Newborn | 2 | 2015 | 25625 | 0.060 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2004 | 190 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 6171 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14557 | 0.060 |
Why?
|
| Fas Ligand Protein | 1 | 2004 | 216 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 2011 | 931 | 0.060 |
Why?
|
| Receptors, Death Domain | 1 | 2003 | 32 | 0.060 |
Why?
|
| Axons | 1 | 2011 | 1684 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 1790 | 0.060 |
Why?
|
| BH3 Interacting Domain Death Agonist Protein | 1 | 2003 | 92 | 0.060 |
Why?
|
| RNA Interference | 2 | 2016 | 2889 | 0.060 |
Why?
|
| Female | 14 | 2018 | 380194 | 0.060 |
Why?
|
| Gene Expression | 2 | 2009 | 7799 | 0.060 |
Why?
|
| Weight Loss | 1 | 2014 | 2622 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3760 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2003 | 330 | 0.050 |
Why?
|
| Genotype | 1 | 2017 | 12951 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2012 | 2969 | 0.050 |
Why?
|
| Cell Line, Tumor | 5 | 2018 | 16689 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1263 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2012 | 3748 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2015 | 10252 | 0.050 |
Why?
|
| Bone Neoplasms | 1 | 2014 | 2529 | 0.050 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2001 | 48 | 0.050 |
Why?
|
| Glioblastoma | 1 | 2017 | 3481 | 0.050 |
Why?
|
| Proteins | 2 | 2015 | 6103 | 0.050 |
Why?
|
| Motor Activity | 1 | 2011 | 2714 | 0.050 |
Why?
|
| Models, Biological | 2 | 2009 | 9583 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2282 | 0.050 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2003 | 452 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2017 | 63114 | 0.050 |
Why?
|
| Longevity | 1 | 2008 | 1070 | 0.050 |
Why?
|
| Age Factors | 2 | 2018 | 18370 | 0.050 |
Why?
|
| Precipitin Tests | 1 | 2001 | 829 | 0.050 |
Why?
|
| Complement C5a | 1 | 2000 | 107 | 0.050 |
Why?
|
| Glycosylation | 1 | 2003 | 1126 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2004 | 1434 | 0.040 |
Why?
|
| Dimerization | 1 | 2001 | 893 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2003 | 2839 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3616 | 0.040 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2019 | 112 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 1285 | 0.040 |
Why?
|
| Immunoblotting | 1 | 2001 | 1682 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12208 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2013 | 3870 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 2726 | 0.040 |
Why?
|
| Cysteine Endopeptidases | 1 | 2000 | 563 | 0.040 |
Why?
|
| Multienzyme Complexes | 1 | 2000 | 686 | 0.040 |
Why?
|
| Nitrobenzoates | 1 | 2016 | 17 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2018 | 6538 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 1678 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 553 | 0.030 |
Why?
|
| Kinetics | 1 | 2004 | 6473 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2017 | 221 | 0.030 |
Why?
|
| Phenotype | 1 | 2013 | 16365 | 0.030 |
Why?
|
| Thymus Gland | 1 | 2000 | 1267 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2014 | 1970 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 2017 | 1827 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 386 | 0.030 |
Why?
|
| Vitamin A | 1 | 1998 | 615 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2007 | 4217 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2015 | 642 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 835 | 0.030 |
Why?
|
| Neurologic Examination | 1 | 2017 | 930 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 3772 | 0.030 |
Why?
|
| Blood Glucose | 2 | 2019 | 6256 | 0.030 |
Why?
|
| Binding Sites | 1 | 2003 | 6114 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3846 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 2948 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
| Th1 Cells | 1 | 1998 | 1057 | 0.030 |
Why?
|
| Middle Aged | 7 | 2018 | 213383 | 0.030 |
Why?
|
| Presynaptic Terminals | 1 | 2014 | 302 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2004 | 4560 | 0.030 |
Why?
|
| Antigens | 1 | 2017 | 1466 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2003 | 4420 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 3617 | 0.030 |
Why?
|
| Inflammation | 1 | 2011 | 10638 | 0.020 |
Why?
|
| Species Specificity | 1 | 2015 | 2478 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2017 | 1538 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 2014 | 2645 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2017 | 2290 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2017 | 3689 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2015 | 6386 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 2505 | 0.020 |
Why?
|
| Glutamic Acid | 1 | 2014 | 1169 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 6314 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2017 | 3557 | 0.020 |
Why?
|
| Cyclooxygenase 2 | 1 | 2011 | 611 | 0.020 |
Why?
|
| Clinical Trials as Topic | 2 | 2017 | 7913 | 0.020 |
Why?
|
| Adult | 5 | 2017 | 214055 | 0.020 |
Why?
|
| Rabbits | 2 | 2006 | 4894 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 23338 | 0.020 |
Why?
|
| Pregnancy | 1 | 2009 | 29144 | 0.020 |
Why?
|
| Prognosis | 2 | 2018 | 29063 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2011 | 1899 | 0.020 |
Why?
|
| Sepsis | 1 | 2000 | 2593 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 728 | 0.020 |
Why?
|
| Isoenzymes | 1 | 2011 | 1726 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9687 | 0.020 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 434 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2915 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2016 | 5974 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 1998 | 4149 | 0.020 |
Why?
|
| Anxiety | 1 | 2019 | 4297 | 0.020 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2014 | 2305 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 813 | 0.010 |
Why?
|
| Sex Factors | 1 | 2018 | 10397 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2018 | 5172 | 0.010 |
Why?
|
| Cytokines | 1 | 1998 | 7322 | 0.010 |
Why?
|
| Cell Count | 1 | 2007 | 1856 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2007 | 1792 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12245 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2016 | 6196 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 996 | 0.010 |
Why?
|
| Aging | 1 | 2000 | 8664 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 2003 | 675 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2000 | 128 | 0.010 |
Why?
|
| Histones | 1 | 2011 | 2599 | 0.010 |
Why?
|
| bcl-Associated Death Protein | 1 | 2000 | 107 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2007 | 2025 | 0.010 |
Why?
|
| Adaptation, Physiological | 1 | 2007 | 1312 | 0.010 |
Why?
|
| Rats, Long-Evans | 1 | 2000 | 387 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 2011 | 2647 | 0.010 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2007 | 1035 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2000 | 295 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2000 | 411 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 573 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 1998 | 370 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2000 | 1801 | 0.010 |
Why?
|
| Mice, Inbred CBA | 1 | 1998 | 448 | 0.010 |
Why?
|
| Recovery of Function | 1 | 2008 | 2925 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1998 | 821 | 0.010 |
Why?
|
| Growth Inhibitors | 1 | 1998 | 385 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 15519 | 0.010 |
Why?
|
| Oxygen | 1 | 2008 | 4189 | 0.010 |
Why?
|
| Glucose | 1 | 2008 | 4397 | 0.010 |
Why?
|
| Organ Size | 1 | 2000 | 2252 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5756 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 2000 | 2187 | 0.010 |
Why?
|
| Antigen-Presenting Cells | 1 | 1998 | 973 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1227 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2007 | 9146 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2000 | 2499 | 0.010 |
Why?
|
| Adolescent | 2 | 2014 | 85781 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 4568 | 0.010 |
Why?
|
| Risk Factors | 1 | 2016 | 72290 | 0.010 |
Why?
|
| Aged | 2 | 2017 | 163280 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2000 | 4554 | 0.000 |
Why?
|
| Young Adult | 1 | 2014 | 56430 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1998 | 5524 | 0.000 |
Why?
|
| Child | 1 | 2014 | 77709 | 0.000 |
Why?
|